The impact of bone marrow adipocytes on osteoblast and osteoclast differentiation

IUBMB Life

Volumn 66, Issue 3, 2014, Pages 147-155

  Muruganandan, Shanmugam ^a   Sinal, Christopher J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

adipocyte; bone remodeling; osteoblast; osteoclast; stem cell

Indexed keywords

ADIPOCYTE; BONE MARROW CELL; BONE REMODELING; CELL COMMUNICATION; CELL DIFFERENTIATION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; REVIEW; STEM CELL;

EID: 84898539887     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1254     Document Type: Review

References (67)

1. Tamma, R., and, Zallone, A., (2012) Osteoblast and osteoclast crosstalks: from OAF to Ephrin. Inflamm. Allergy Drug Targets 11, 196-200.
2. Andersen, T. L., Abdelgawad, M. E., Kristensen, H. B., Hauge, E. M., Rolighed, L., et al. (2013) Understanding coupling between bone resorption and formation: are reversal cells the missing link? Am. J. Pathol. 183, 235-246.
3. Raggatt, L. J., and, Partridge, N. C., (2010) Cellular and molecular mechanisms of bone remodeling. J. Biol. Chem. 285, 25103-25108.
4. Muruganandan, S., Roman, A. A., and, Sinal, C. J., (2009) Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol. Life Sci. 66, 236-253.
5. Botolin, S., and, McCabe, L. R., (2007) Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 148, 198-205.
6. Justesen, J., Stenderup, K., Ebbesen, E. N., Mosekilde, L., Steiniche, T., et al. (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2, 165-171.
7. Xie, H., Tang, S. Y., Luo, X. H., Huang, J., Cui, R. R., et al. (2007) Insulin-like effects of visfatin on human osteoblasts. Calcif. Tissue Int. 80, 201-210.
8. Thommesen, L., Stunes, A. K., Monjo, M., Grosvik, K., Tamburstuen, M. V., et al. (2006) Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J. Cell. Biochem. 99, 824-834.
9. Holloway, W. R., Collier, F. M., Aitken, C. J., Myers, D. E., Hodge, J. M., et al. (2002) Leptin inhibits osteoclast generation. J. Bone Miner. Res. 17, 200-209.
10. Tu, Q., Zhang, J., Dong, L. Q., Saunders, E., Luo, E., et al. (2011) Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J. Biol. Chem. 286, 12542-12553.
11. Muruganandan, S., Dranse, H. J., Rourke, J. L., McMullen, N. M., and, Sinal, C. J., (2013) Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells 31, 2172-2182.
12. Muruganandan, S., Roman, A. A., and, Sinal, C. J., (2010) Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J. Bone Miner. Res. 25, 222-234.
13. Corral, D. A., Amling, M., Priemel, M., Loyer, E., Fuchs, S., et al. (1998) Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc. Natl. Acad. Sci. USA 95, 13835-13840.
14. Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-Hora, M., et al. (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17, 1231-1234.
15. Ota, K., Quint, P., Weivoda, M. M., Ruan, M., Pederson, L., et al. (2013) Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors. Bone 57, 68-75.
16. Bonewald, L. F., and, Mundy, G. R., (1990) Role of transforming growth factor-beta in bone remodeling. Clin. Orthop. Relat. Res. 261-276.
17. Ortuno, M. J., Susperregui, A. R., Artigas, N., Rosa, J. L., and, Ventura, F., (2013) Osterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions. Bone 52, 548-556.
18. Kim, Y. J., Lee, M. H., Wozney, J. M., Cho, J. Y., and, Ryoo, H. M., (2004) Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J. Biol. Chem. 279, 50773-50780.
19. Mendez-Ferrer, S., Michurina, T. V., Ferraro, F., Mazloom, A. R., Macarthur, B. D., et al. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829-834.
20. Kondo, M., (2010) Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. Immunol. Rev. 238, 37-46.
21. Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., et al. (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. USA 87, 7260-7264.
22. Adams, G. B., Chabner, K. T., Alley, I. R., Olson, D. P., Szczepiorkowski, Z. M., et al. (2006) Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439, 599-603.
23. Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., et al. (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841-846.
24. Wright, H. L., McCarthy, H. S., Middleton, J., and, Marshall, M. J., (2009) RANK, RANKL and osteoprotegerin in bone biology and disease. Curr. Rev. Musculoskelet. Med. 2, 56-64.
25. Asagiri, M., and, Takayanagi, H., (2007) The molecular understanding of osteoclast differentiation. Bone 40, 251-264.
26. Thomas, G. P., Baker, S. U., Eisman, J. A., and, Gardiner, E. M., (2001) Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J. Endocrinol. 170, 451-460.
27. Gori, F., Hofbauer, L. C., Dunstan, C. R., Spelsberg, T. C., Khosla, S., et al. (2000) The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141, 4768-4776.
28. Sato, M. M., Nakashima, A., Nashimoto, M., Yawaka, Y., and, Tamura, M., (2009) Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression. Genes Cells 14, 141-153.
29. Wijenayaka, A. R., Kogawa, M., Lim, H. P., Bonewald, L. F., Findlay, D. M., et al. (2011) Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One 6, e25900.
30. Silvestrini, G., Ballanti, P., Leopizzi, M., Gualtieri, N., Sardella, D., et al. (2007) Effects of the administration of corticosterone, parathyroid hormone, or both, and of their withdrawal, on rat bone and cartilage histomorphometric parameters, and on osteoprotegerin and RANKL mRNA expression and proteins. J. Mol. Histol. 38, 215-226.
31. Liu, X. H., Kirschenbaum, A., Yao, S., and, Levine, A. C., (2006) Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system. Ann. N. Y. Acad. Sci. 1068, 225-233.
32. Ryu, J., Kim, H. J., Chang, E. J., Huang, H., Banno, Y., et al. (2006) Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 25, 5840-5851.
33. Pederson, L., Ruan, M., Westendorf, J. J., Khosla, S., and, Oursler, M. J., (2008) Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc. Natl. Acad. Sci. USA 105, 20764-20769.
34. Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., et al. (2006) Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 4, 111-121.
35. Kusu, N., Laurikkala, J., Imanishi, M., Usui, H., Konishi, M., et al. (2003) Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J. Biol. Chem. 278, 24113-24117.
36. Negishi-Koga, T., Shinohara, M., Komatsu, N., Bito, H., Kodama, T., et al. (2011) Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat. Med. 17, 1473-1480.
37. Martin, T. J., and, Sims, N. A., (2005) Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11, 76-81.
38. Quinn, J. M., Itoh, K., Udagawa, N., Hausler, K., Yasuda, H., et al. (2001) Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J. Bone Miner. Res. 16, 1787-1794.
39. Ota, K., Quint, P., Ruan, M., Pederson, L., Westendorf, J. J., et al. (2013) TGF-beta induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts. Endocrinology 154, 3745-3752.
40. Akune, T., Ohba, S., Kamekura, S., Yamaguchi, M., Chung, U. I., et al. (2004) PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 113, 846-855.
41. Rodriguez, J. P., Montecinos, L., Rios, S., Reyes, P., and, Martinez, J., (2000) Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J. Cell. Biochem. 79, 557-565.
42. Mauney, J., and, Volloch, V., (2009) Progression of human bone marrow stromal cells into both osteogenic and adipogenic lineages is differentially regulated by structural conformation of collagen I matrix via distinct signaling pathways. Matrix Biol. 28, 239-250.
43. Wan, Y., Chong, L. W., and, Evans, R. M., (2007) PPAR-gamma regulates osteoclastogenesis in mice. Nat. Med. 13, 1496-1503.
44. Evans, B. A., Bull, M. J., Kench, R. C., Fox, R. E., Morgan, L. D., et al. (2011) The influence of leptin on trabecular architecture and marrow adiposity in GH-deficient rats. J. Endocrinol. 208, 69-79.
45. Astudillo, P., Rios, S., Pastenes, L., Pino, A. M., and, Rodriguez, J. P., (2008) Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action. J. Cell. Biochem. 103, 1054-1065.
46. Thomas, T., (2004) The complex effects of leptin on bone metabolism through multiple pathways. Curr. Opin. Pharmacol. 4, 295-300.
47. Liu, L. F., Shen, W. J., Zhang, Z. H., Wang, L. J., and, Kraemer, F. B., (2010) Adipocytes decrease Runx2 expression in osteoblastic cells: roles of PPARgamma and adiponectin. J. Cell Physiol. 225, 837-845.
48. Lee, H. W., Kim, S. Y., Kim, A. Y., Lee, E. J., Choi, J. Y., et al. (2009) Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells 27, 2254-2262.
49. Yamaguchi, N., Kukita, T., Li, Y. J., Kamio, N., Fukumoto, S., et al. (2008) Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett. 582, 451-456.
50. Luo, X. H., Guo, L. J., Xie, H., Yuan, L. Q., Wu, X. P., et al. (2006) Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J. Bone Miner. Res. 21, 1648-1656.
51. Araneta, M. R., von Muhlen, D., and, Barrett-Connor, E., (2009) Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the Rancho Bernardo study. J. Bone Miner. Res. 24, 2016-2022.
52. Kanazawa, I., Yamaguchi, T., and, Sugimoto, T., (2010) Baseline serum total adiponectin level is positively associated with changes in bone mineral density after 1-year treatment of type 2 diabetes mellitus. Metabolism 59, 1252-1256.
53. Goralski, K. B., McCarthy, T. C., Hanniman, E. A., Zabel, B. A., Butcher, E. C., et al. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282, 28175-28188.
54. Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., et al. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148, 4687-4694.
55. Muruganandan, S., Parlee, S. D., Rourke, J. L., Ernst, M. C., Goralski, K. B., et al. (2011) Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J. Biol. Chem. 286, 23982-23995.
56. Xie, H., Xie, P. L., Luo, X. H., Wu, X. P., Zhou, H. D., et al. (2012) Omentin-1 exerts bone-sparing effect in ovariectomized mice. Osteoporos. Int. 23, 1425-1436.
57. Moschen, A. R., Geiger, S., Gerner, R., and, Tilg, H., (2010) Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease. Mutat. Res. 690, 95-101.
58. Wu, S. S., Liang, Q. H., Liu, Y., Cui, R. R., Yuan, L. Q., et al. (2013) Omentin-1 stimulates human osteoblast proliferation through PI3K/Akt signal pathway. Int. J. Endocrinol. 2013, 368970.
59. Goto, H., Osaki, M., Fukushima, T., Sakamoto, K., Hozumi, A., et al. (2011) Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression. Biomed. Res. 32, 37-44.
60. Hozumi, A., Osaki, M., Goto, H., Sakamoto, K., Inokuchi, S., et al. (2009) Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. Biochem. Biophys. Res. Commun. 382, 780-784.
61. Wu, X., Pang, L., Lei, W., Lu, W., Li, J., et al. (2010) Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 7, 571-580.
62. Proell, V., Xu, H., Schuler, C., Weber, K., Hofbauer, L. C., et al. (2009) Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats. Bone 45, 677-681.
63. Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., et al. (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111, 1221-1230.
64. Cummings, S. R., San Martin, J., McClung, M. R., Siris, E. S., Eastell, R., et al. (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N. Engl. J. Med. 361, 756-765.
65. Furuya, Y., Mori, K., Ninomiya, T., Tomimori, Y., Tanaka, S., et al. (2011) Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts. J. Biol. Chem. 286, 37023-37031.
66. Pino, A. M., Rosen, C. J., and, Rodriguez, J. P., (2012) In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis. Biol. Res. 45, 279-287.
67. Savopoulos, C., Dokos, C., Kaiafa, G., and, Hatzitolios, A., (2011) Adipogenesis and osteoblastogenesis: trans-differentiation in the pathophysiology of bone disorders. Hippokratia 15, 18-21.